AI assistant
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2015
May 8, 2015
32163_dirs_2015-05-08_28106799-119e-412b-9603-0e8b068de1d2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2015-05-06
Reporting Person: Longitude Capital Partners, LLC (10% Owner)
Reporting Person: Longitude Capital Associates, L.P. (10% Owner)
Reporting Person: Longitude Venture Partners L.P. (10% Owner)
Reporting Person: Tammenoms Bakker Juliet (10% Owner)
Reporting Person: ENRIGHT PATRICK G (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series B Convertible Preferred Stock | $0.00 | Common Stock (1860570) | Indirect | ||
| Series B Convertible Preferred Stock | $0.00 | Common Stock (37290) | Indirect | ||
| Series C Convertible Preferred Stock | $0.00 | Common Stock (458102) | Indirect | ||
| Series C Convertible Preferred Stock | $0.00 | Common Stock (9182) | Indirect | ||
| Series D Convertible Preferred Stock | $0.00 | Common Stock (731214) | Indirect | ||
| Series D Convertible Preferred Stock | $0.00 | Common Stock (14656) | Indirect |
Footnotes
F1: All series of Convertible Preferred Stock will automatically convert into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis immediately prior to the closing of the initial public offering and have no expiration date.
F2: This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA"), Patrick G. Enright ("Enright") and Juliet Tammenoms Bakker ("Bakker"), all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. LCP, as general partner of each of LVP and LCA, has the power to vote and dispose of securities held by each of them and may be deemed to have beneficial ownership of the shares owned by LVP and LCA. Enright and Bakker are each managing members of LCP and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by the reporting persons. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.